(Q51466225)

5 April 2018

title

Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model. (English)

1 reference

5 April 2018

author

Giuseppe Remuzzi

8

1 reference

5 April 2018

Ariela Benigni

1

object named as

Benigni A

1 reference

5 April 2018

Zoja C

2

1 reference

5 April 2018

Noris M

3

1 reference

5 April 2018

Corna D

4

1 reference

5 April 2018

Benedetti G

5

1 reference

5 April 2018

Bruzzi I

6

1 reference

5 April 2018

Todeschini M

7

1 reference

5 April 2018

publication date

1 April 1999

1 reference

5 April 2018

American Journal of Kidney Diseases

published in

1 reference

5 April 2018

volume

33

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

746-753

1 reference

5 April 2018

Understanding the nature of renal disease progression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

The role of hemodynamic factors in the initiation and progression of renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Renal and systemic nitric oxide synthesis in rats with renal mass reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Light stability of molsidomine in infusion fluids.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

The delayed effect of growth hormone on renal function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Long-term enalapril and verapamil in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Contribution of systemic blood pressure to myocardial remodeling in uremic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970229-5

7 January 2021

10.1016/S0272-6386(99)70229-5

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

10196019

1 reference

5 April 2018